Literature DB >> 16114095

Inhibition of cyclo-oxygenase-2 expression in mouse macrophages by 4-(3-methyl-but-1-enyl)-3,5,3',4'-tetrahydroxystilbene, a resveratrol derivative from peanuts.

Bankim Patel1, Sandip Patel, Richard Hoffman.   

Abstract

Resveratrol derivatives are of interest as inhibitors of cyclo-oxygenase-2 and as antiinflammatory agents. The prenylated resveratrol derivative 4-(3-methyl-but-1-enyl)-3,5,3',4'-tetrahydroxystilbene was purified from fungally infected peanuts by thin layer chromatography and its structure was confirmed by mass spectrometry. 4-(3-Methyl-but-1-enyl)-3,5,3',4'-tetrahydroxystilbene inhibited lipopolysaccharide-induced expression of cyclo-oxygenase-2 protein and cyclo-oxygenase-2 mRNA in mouse macrophages at concentrations that were non-cytotoxic. 4-(3-Methyl-but-1-enyl)-3,5,3',4'-tetrahydroxystilbene warrants further evaluation as an antiinflammatory agent. Copyright (c) 2005 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16114095     DOI: 10.1002/ptr.1698

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  3 in total

1.  Low concentrations of resveratrol inhibit Wnt signal throughput in colon-derived cells: implications for colon cancer prevention.

Authors:  Christopher Hope; Kestutis Planutis; Marina Planutiene; Mary P Moyer; Karanjodh S Johal; Jaesung Woo; Calista Santoso; Joseph A Hanson; Randall F Holcombe
Journal:  Mol Nutr Food Res       Date:  2008-06       Impact factor: 5.914

2.  Systematic review of herbals as potential anti-inflammatory agents: Recent advances, current clinical status and future perspectives.

Authors:  Sarwar Beg; Suryakanta Swain; Hameed Hasan; M Abul Barkat; Md Sarfaraz Hussain
Journal:  Pharmacogn Rev       Date:  2011-07

3.  Resveratrol sensitizes tamoxifen in antiestrogen-resistant breast cancer cells with epithelial-mesenchymal transition features.

Authors:  Xiao-Peng Shi; Shan Miao; Yin Wu; Wei Zhang; Xiao-Fang Zhang; Hua-Zhao Ma; Hai-Li Xin; Juan Feng; Ai-Dong Wen; Yan Li
Journal:  Int J Mol Sci       Date:  2013-07-26       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.